To assess changes in Ocular Response Analyzer ( ORA ) waveforms after UVA/riboflavin corneal collagen cross-linking ( CXL ) using investigator-derived and manufacturer-supplied morphometric variables in patients with keratoconus ( KC ) and postrefractive surgery ectasia .